| Year |
Citation |
Score |
| 2024 |
Gu J, Chery L, González GMN, Huff C, Strom S, Jones JA, Griffith DP, Canfield SE, Wang X, Huang X, Roberson P, Meng QH, Troncoso P, Ittmann M, Covinsky M, et al. A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening. The Prostate. PMID 38477020 DOI: 10.1002/pros.24686 |
0.35 |
|
| 2023 |
Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, Darst BF, Sheng X, Xu Y, Chou AJ, Benlloch S, Dadaev T, Brook MN, Plym A, Sahimi A, ... ... Strom SS, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics. PMID 37945903 DOI: 10.1038/s41588-023-01534-4 |
0.407 |
|
| 2023 |
Chen F, Madduri RK, Rodriguez AA, Darst BF, Chou A, Sheng X, Wang A, Shen J, Saunders EJ, Rhie SK, Bensen JT, Ingles SA, Kittles RA, Strom SS, Rybicki BA, et al. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. European Urology. PMID 36872133 DOI: 10.1016/j.eururo.2023.01.022 |
0.386 |
|
| 2022 |
Darst BF, Hughley R, Pfennig A, Hazra U, Fan C, Wan P, Sheng X, Xia L, Andrews C, Chen F, Berndt SI, Kote-Jarai Z, Govindasami K, Bensen JT, Ingles SA, ... ... Strom SS, et al. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry. European Urology. PMID 35031163 DOI: 10.1016/j.eururo.2021.12.023 |
0.423 |
|
| 2021 |
Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, ... ... Strom SS, et al. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics. PMID 33473200 DOI: 10.1038/s41588-021-00786-2 |
0.328 |
|
| 2021 |
Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, ... ... Strom SS, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics. PMID 33398198 DOI: 10.1038/s41588-020-00748-0 |
0.419 |
|
| 2020 |
Darst BF, Wan P, Sheng X, Bensen JT, Ingles SA, Rybicki BA, Nemesure B, John EM, Fowke JH, Stevens VL, Berndt SI, Huff CD, Strom SS, Park JY, Zheng W, et al. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. European Urology. PMID 32409115 DOI: 10.1016/J.Eururo.2020.04.060 |
0.373 |
|
| 2019 |
Du Z, Hopp H, Ingles SA, Huff C, Sheng X, Weaver B, Stern M, Hoffmann TJ, John EM, Van Den Eeden SK, Strom S, Leach RJ, Thompson IM, Witte JS, Conti DV, et al. A Genome-wide Association Study of Prostate Cancer in Latinos. International Journal of Cancer. PMID 31226226 DOI: 10.1002/Ijc.32525 |
0.413 |
|
| 2018 |
Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, ... ... Strom SS, et al. Germline variation at 8q24 and prostate cancer risk in men of European ancestry. Nature Communications. 9: 4616. PMID 30397198 DOI: 10.1038/S41467-018-06863-1 |
0.408 |
|
| 2018 |
Mikropoulos C, Hutten Selkirk CG, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, ... ... Strom S, et al. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. British Journal of Cancer. PMID 29509747 DOI: 10.1038/bjc.2018.11 |
0.327 |
|
| 2018 |
Mikropoulos C, Selkirk CGH, Saya S, Bancroft E, Vertosick E, Dadaev T, Brendler C, Page E, Dias A, Evans DG, Rothwell J, Maehle L, Axcrona K, Richardson K, Eccles D, ... ... Strom S, et al. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. British Journal of Cancer. PMID 29301143 DOI: 10.1038/Bjc.2017.429 |
0.445 |
|
| 2018 |
Matejcic M, Saunders EJ, Dadaev T, Brook M, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Muir K, Govindasami K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, ... ... Strom S, et al. Abstract 227: Germline variation at 8q24 and prostate cancer risk in men of European ancestry Epidemiology. DOI: 10.1158/1538-7445.Am2018-227 |
0.472 |
|
| 2017 |
Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, et al. Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. Journal of the National Cancer Institute. 109. PMID 29117387 DOI: 10.1093/Jnci/Djx084 |
0.388 |
|
| 2017 |
Tu H, Gu J, Meng QH, Kim J, Strom S, Davis JW, He Y, Wagar EA, Thompson TC, Logothetis CJ, Wu X. Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer. Oncology Letters. 13: 1949-1957. PMID 28454349 DOI: 10.3892/Ol.2017.5616 |
0.455 |
|
| 2017 |
Hopp H, Ingles S, Huff C, Sheng X, Weaver B, Stern M, Strom S, Thompson I, Conti D, Haiman CA. Abstract 1303: A genome-wide association study of prostate cancer in Latinos Cancer Research. 77: 1303-1303. DOI: 10.1158/1538-7445.Am2017-1303 |
0.484 |
|
| 2016 |
Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, et al. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nature Communications. 7: 10979. PMID 27052111 DOI: 10.1038/Ncomms10979 |
0.344 |
|
| 2016 |
Falchi L, Vitale C, Keating MJ, Lerner S, Wang X, Elhor Gbito KY, Strom S, Wierda WG, Ferrajoli A. Incidence and Prognostic Impact of Other Cancers in a Population of Long-Term Survivors of Chronic Lymphocytic Leukemia. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26912560 DOI: 10.1093/Annonc/Mdw072 |
0.308 |
|
| 2016 |
Han Y, Rand KA, Hazelett DJ, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Schumacher FR, Berndt SI, Wang Z, Xu J, et al. Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. Journal of the National Cancer Institute. 108. PMID 26823525 DOI: 10.1093/Jnci/Djv431 |
0.4 |
|
| 2015 |
Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy. American Journal of Men's Health. PMID 25891393 DOI: 10.1177/1557988315581396 |
0.605 |
|
| 2015 |
Ludwig MS, Kuban DA, Du XL, Lopez DS, Yamal JM, Strom SS. The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation. Bmc Cancer. 15: 190. PMID 25885406 DOI: 10.1186/S12885-015-1180-6 |
0.593 |
|
| 2015 |
Chow WH, Chrisman M, R Daniel C, Ye Y, Gomez H, Dong Q, Anderson CE, Chang S, Strom S, Zhao H, Wu X. Cohort Profile: The Mexican American Mano a Mano Cohort. International Journal of Epidemiology. PMID 25747868 DOI: 10.1093/Ije/Dyv016 |
0.384 |
|
| 2015 |
Benjamini O, Jain P, Trinh L, Qiao W, Strom SS, Lerner S, Wang X, Burger J, Ferrajoli A, Kantarjian H, O'Brien S, Wierda W, Estrov Z, Keating M. Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes. Leukemia & Lymphoma. 56: 1643-50. PMID 25308294 DOI: 10.3109/10428194.2014.957203 |
0.338 |
|
| 2015 |
Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, et al. Generalizability of established prostate cancer risk variants in men of African ancestry. International Journal of Cancer. Journal International Du Cancer. 136: 1210-7. PMID 25044450 DOI: 10.1002/Ijc.29066 |
0.412 |
|
| 2015 |
Palacios C, Daniel CR, Tirado-Gómez M, Gonzalez-Mercado V, Liliana L, Lozada J, Hughes DC, Strom S, Basen-Engquist K. Abstract B14: Dietary patterns in Puerto Rican and Mexican-American breast cancer survivors: A pilot study Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B14 |
0.356 |
|
| 2014 |
He Y, Gu J, Strom S, Logothetis CJ, Kim J, Wu X. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5133-9. PMID 25274378 DOI: 10.1158/1078-0432.Ccr-14-0661 |
0.483 |
|
| 2014 |
Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, ... ... Strom SS, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature Genetics. 46: 1103-9. PMID 25217961 DOI: 10.1038/Ng.3094 |
0.413 |
|
| 2014 |
Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, ... ... Strom S, et al. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study. European Urology. 66: 489-99. PMID 24484606 DOI: 10.1016/J.Eururo.2014.01.003 |
0.455 |
|
| 2014 |
Han L, Zhao H, Strom S, Daniel CR, Chang D, Zhang H, Ye Y, Gu J, Chow W, Wu X. Abstract 5038: Telomere length linking social contexts and cancer risk in Mexican Americans Cancer Research. 74: 5038-5038. DOI: 10.1158/1538-7445.Am2014-5038 |
0.395 |
|
| 2013 |
Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, ... ... Strom S, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013: 560857. PMID 23476788 DOI: 10.1155/2013/560857 |
0.421 |
|
| 2013 |
Falchi L, Keating MJ, Lerner S, Wang X, Strom S, Wierda WG, Ferrajoli A. Other Cancers in Patients With Chronic Lymphocytic Leukemia Requiring Therapy: Association With Prognostic Factors and Impact on Survival Clinical Lymphoma Myeloma and Leukemia. 13: S364. DOI: 10.1016/J.Clml.2013.07.057 |
0.371 |
|
| 2012 |
Hosain GM, Sanderson M, Du XL, Chan W, Strom SS. Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population. American Journal of Men's Health. 6: 249-57. PMID 22419652 DOI: 10.1177/1557988311432467 |
0.675 |
|
| 2011 |
Verma D, Kantarjian H, Strom SS, Rios MB, Jabbour E, Quintas-Cardama A, Verstovsek S, Ravandi F, O'Brien S, Cortes J. Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies. Blood. 118: 4353-8. PMID 21846902 DOI: 10.1182/blood-2011-06-362889 |
0.327 |
|
| 2011 |
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Chanock SJ, Kolb S, Signorello LB, et al. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. Plos Genetics. 7: e1001387. PMID 21637779 DOI: 10.1371/Journal.Pgen.1001387 |
0.423 |
|
| 2011 |
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nature Genetics. 43: 570-3. PMID 21602798 DOI: 10.1038/Ng.839 |
0.403 |
|
| 2011 |
Hosain GM, Sanderson M, Du XL, Chan W, Strom SS. Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population. Central European Journal of Public Health. 19: 30-4. PMID 21526653 DOI: 10.21101/Cejph.A3622 |
0.68 |
|
| 2011 |
Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, et al. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 23-32. PMID 21071540 DOI: 10.1158/1055-9965.Epi-10-0698 |
0.332 |
|
| 2011 |
Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C, Mitchell G, Lindeman GJ, Stapleton A, Suthers G, Evans DG, Cruger D, Blanco I, Mercer C, Kirk J, ... ... Strom S, et al. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. Bju International. 107: 28-39. PMID 20840664 DOI: 10.1111/J.1464-410X.2010.09648.X |
0.444 |
|
| 2011 |
Coombs CC, Rassenti LZ, Slager SL, Strom S, Weinberg JB, Kipps TJ, Lanasa MC. Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia Blood. 118: 1785-1785. DOI: 10.1182/Blood.V118.21.1785.1785 |
0.352 |
|
| 2011 |
Lopez DS, Garoma L, Waring SC, Bondy M, Forman M, Strom S. Abstract B94: Relationship of overweight and diabetes with prostate cancer stages in Mexican Americans: A population-based case-control study Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-B94 |
0.401 |
|
| 2011 |
Falchi L, Lerner S, Wierda WG, O'Brien S, Faderl S, Strom S, Abbruzo L, Keating MJ, Ferrajoli A. 3.19 Disease Characteristics and Response to First Therapy in African American Patients with CLL: the M.D. Anderson Cancer Center Experience Clinical Lymphoma Myeloma and Leukemia. 11: S209-S210. DOI: 10.1016/J.Clml.2011.09.108 |
0.346 |
|
| 2010 |
Slager S, Rabe K, Achenbach S, Vachon C, Goldin L, Strom S, Lanasa MC, Spector LG, Rassenti LZ, Leis J, Camp N, Glenn M, Kay NE, Cunningham JM, Hanson CA, et al. Investigation of CLL-Susceptibility Loci with Monoclonal B-Cell Lymphocytosis (MBL) Risk and Confirmation of Recently Reported CLL-Susceptibility Loci Blood. 116: 2443-2443. DOI: 10.1182/Blood.V116.21.2443.2443 |
0.312 |
|
| 2010 |
Blando JM, Moore T, Beltran L, Jiang G, Strom S, Hursting S, DiGiovanni J. Abstract 943: Obesity, P13k/Akt/mTOR signaling and prostate carcinogenesis in HiMyc mice Cancer Research. 70: 943-943. DOI: 10.1158/1538-7445.Am10-943 |
0.405 |
|
| 2009 |
Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S, Strom S, Freireich EJ, Medeiros LJ, Kantarjian HM, Keating MJ. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 904-10. PMID 19114699 DOI: 10.1200/Jco.2008.17.5398 |
0.452 |
|
| 2008 |
Moore T, Beltran L, Carbajal S, Strom S, Traag J, Hursting SD, DiGiovanni J. Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. Cancer Prevention Research (Philadelphia, Pa.). 1: 65-76. PMID 19138937 DOI: 10.1158/1940-6207.Capr-08-0022 |
0.301 |
|
| 2008 |
Pettaway CA, Song R, Wang X, Sanchez-Ortiz R, Spiess PE, Strom S, Troncoso P. The ratio of matrix metalloproteinase to E-cadherin expression: a pilot study to assess mRNA and protein expression among African American prostate cancer patients. The Prostate. 68: 1467-76. PMID 18618693 DOI: 10.1002/Pros.20812 |
0.382 |
|
| 2008 |
Strom SS, Yamamura Y, Flores-Sandoval FN, Pettaway CA, Lopez DS. Prostate cancer in Mexican-Americans: identification of risk factors. The Prostate. 68: 563-70. PMID 18247399 DOI: 10.1002/pros.20713 |
0.382 |
|
| 2008 |
Dayyani F, Conley AP, Pierce S, Strom S, Stevenson W, Borthakur G, Kantarjian H, Garcia-Manero G. Disease-Related Mortality in Patients with Lower-Risk Myelodysplastic Syndrome (MDS) Blood. 112: 5073-5073. DOI: 10.1182/Blood.V112.11.5073.5073 |
0.338 |
|
| 2008 |
Strom S, Gokhale S, Estey E. Abstract A107: Polymorphisms in nucleotide excision repair pathway and acute myeloid leukemia outcome Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-A107 |
0.367 |
|
| 2008 |
Pettaway CA, Song R, Wang X, Liu J, McDonnell T, Black PC, Prokhorova I, Soto C, Strom S, Troncoso P. RACIAL VARIATION IN THE MATRIX METALLOPROTEINASE: E-CADHERIN RATIO IN LOCALIZED PROSTATE CANCER: RESULTS FROM A CONTEMPORARY MATCHED COMPARATIVE STUDY Journal of Urology. 179: 421-422. DOI: 10.1016/S0022-5347(08)61235-5 |
0.42 |
|
| 2006 |
El-Zein R, Etzel CJ, Lopez MS, Gu Y, Spitz MR, Strom SS. Human sensitivity to PhIP: a novel marker for prostate cancer risk. Mutation Research. 601: 1-10. PMID 16889804 DOI: 10.1016/J.Mrfmmm.2006.05.023 |
0.597 |
|
| 2006 |
Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR, Pisters LL, Lee AK, Rosser CJ, Kuban DA. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer. 107: 631-9. PMID 16802288 DOI: 10.1002/Cncr.22025 |
0.528 |
|
| 2005 |
Chang S, Erdman JW, Clinton SK, Vadiveloo M, Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Amos CI, Contois JH, Gu X, Babaian RJ, Scardino PT, Hursting SD. Relationship between plasma carotenoids and prostate cancer. Nutrition and Cancer. 53: 127-34. PMID 16573373 DOI: 10.1207/S15327914Nc5302_1 |
0.328 |
|
| 2005 |
Strom SS, Wang X, Pettaway CA, Logothetis CJ, Yamamura Y, Do KA, Babaian RJ, Troncoso P. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6889-94. PMID 16203779 DOI: 10.1158/1078-0432.CCR-04-1977 |
0.343 |
|
| 2005 |
Strom SS, Gu Y, Gruschkus SK, Pierce SA, Estey EH. Risk factors of myelodysplastic syndromes: a case-control study. Leukemia. 19: 1912-8. PMID 16167059 DOI: 10.1038/Sj.Leu.2403945 |
0.487 |
|
| 2005 |
El-Zein R, Gu Y, Sierra MS, Spitz MR, Strom SS. Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 748-52. PMID 15767363 DOI: 10.1158/1055-9965.Epi-04-0236 |
0.543 |
|
| 2004 |
Strom SS, Gu Y, Zhang H, Troncoso P, Babaian RJ, Pettaway CA, Shete S, Spitz MR, Logothetis CJ. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. The Prostate. 60: 343-51. PMID 15264247 DOI: 10.1002/Pros.20060 |
0.565 |
|
| 2004 |
Cyrus-David MS, Strom S. Epidemiologic predictors of the risk of clinical recurrence in men diagnosed with prostate cancer Journal of Clinical Oncology. 22: 4658-4658. DOI: 10.1200/jco.2004.22.14_suppl.4658 |
0.378 |
|
| 2004 |
Gu Y, Strom SS, Lerner S, Keating MJ. Second Cancers after CLL Diagnosis. Blood. 104: 18-18. DOI: 10.1182/Blood.V104.11.18.18 |
0.58 |
|
| 2003 |
Liu Z, Wang LE, Strom SS, Spitz MR, Babaian RJ, DiGiovanni J, Wei Q. Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis. Molecular Carcinogenesis. 36: 123-9. PMID 12619034 DOI: 10.1002/Mc.10108 |
0.347 |
|
| 2003 |
Radcliffe J, Hernandez L, Pillow P, Elmore D, Strom S. COMPLIANCE WITH THE RDA FOR VITAMIN E IN HEALTHY MEN FROM THREE ETHNIC GROUPS: IMPLICATIONS FOR THE PREVENTION OF PROSTATE CANCER Journal of the American Dietetic Association. 103: 93. DOI: 10.1016/S0002-8223(08)70148-2 |
0.31 |
|
| 2002 |
Walcott FL, Hauptmann M, Duphorne CM, Pillow PC, Strom SS, Sigurdson AJ. A case-control study of dietary phytoestrogens and testicular cancer risk. Nutrition and Cancer. 44: 44-51. PMID 12672640 DOI: 10.1207/S15327914NC441_6 |
0.305 |
|
| 2002 |
Zhu Y, Spitz MR, Strom S, Tomlinson GE, Amos CI, Minna JD, Wu X. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer. International Journal of Cancer. Journal International Du Cancer. 102: 536-40. PMID 12432559 DOI: 10.1002/Ijc.10762 |
0.331 |
|
| 2001 |
Yin Z, Babaian RJ, Troncoso P, Strom SS, Spitz MR, Caudell JJ, Stein JD, Kagan J. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene. 20: 2273-80. PMID 11402322 DOI: 10.1038/Sj.Onc.1204310 |
0.304 |
|
| 2001 |
Strom SS, Spitz MR, Yamamura Y, Babaian RJ, Scardino PT, Wei Q. Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study. The Prostate. 47: 269-75. PMID 11398174 DOI: 10.1002/Pros.1071 |
0.375 |
|
| 2001 |
Chang S, Hursting SD, Contois JH, Strom SS, Yamamura Y, Babaian RJ, Troncoso P, Scardino PS, Wheeler TM, Amos CI, Spitz MR. Leptin and prostate cancer. The Prostate. 46: 62-7. PMID 11170133 DOI: 10.1002/1097-0045(200101)46:1<62::Aid-Pros1009>3.0.Co;2-V |
0.322 |
|
| 2000 |
Spitz MR, Strom SS, Yamamura Y, Troncoso P, Babaian RJ, Scardino PT, Wheeler T, Amos CI, von Eschenbach A, Kagan J. Epidemiologic determinants of clinically relevant prostate cancer. International Journal of Cancer. Journal International Du Cancer. 89: 259-64. PMID 10861502 DOI: 10.1002/1097-0215(20000520)89:3<259::Aid-Ijc8>3.0.Co;2-F |
0.357 |
|
| 1999 |
Sigurdson AJ, Chang S, Annegers JF, Duphorne CM, Pillow PC, Amato RJ, Hutchinson LP, Sweeney AM, Strom SS. A case-control study of diet and testicular carcinoma Nutrition and Cancer. 34: 20-26. PMID 10453437 DOI: 10.1207/S15327914NC340103 |
0.316 |
|
| 1999 |
Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, Pillow PC, Hursting SD. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutrition and Cancer. 33: 20-5. PMID 10227039 DOI: 10.1080/01635589909514743 |
0.387 |
|
| 1998 |
Strom SS, Gu Y, Sigurdson AJ, Bailey NM, Amos CI, Spitz MR, Rodriguez MA, Liang JC. Chromosome breaks and sister chromatid exchange as predictors of second cancers in Hodgkin's disease. Leukemia & Lymphoma. 28: 561-6. PMID 9613986 DOI: 10.3109/10428199809058364 |
0.565 |
|
| 1997 |
Estey E, deLima M, Strom S, Pierce S, Freireich EJ, Keating MJ. Long-term follow-up of patients with newly diagnosed acute myeloid leukemia treated at the University of Texas M.D. Anderson Cancer Center. Cancer. 80: 2176-80. PMID 9395030 DOI: 10.1002/(Sici)1097-0142(19971201)80:11+<2176::Aid-Cncr2>3.0.Co;2-G |
0.373 |
|
| Show low-probability matches. |